Professor of Medicine, Department of Medicine, Pulmonary and Critical Care Medicine, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Dr. Tapson has been interested in pulmonary vascular disease since beginning his career at Duke University several decades ago. Since that time, he has done thousands of inpatient and outpatient consultations for acute pulmonary embolism and pulmonary hypertension patients and served on the steering committee for the epoprostenol trial in IPAH published in 1996. He has also lead and participated in single-center as well as multicenter world-wide clinical trials. Since leaving Duke for an exciting opportunity at Cedars-Sinai in 2014, he has continued this work.